Venture Life Group (VLG) Competitors

GBX 41.50
-0.75 (-1.78%)
(As of 04/26/2024 ET)

VLG vs. EAH, CEL, PXS, ANCR, AGY, BXP, APH, POLB, SPEC, and ETX

Should you be buying Venture Life Group stock or one of its competitors? The main competitors of Venture Life Group include ECO Animal Health Group (EAH), Celadon Pharmaceuticals (CEL), Provexis (PXS), Animalcare Group (ANCR), Allergy Therapeutics (AGY), Beximco Pharmaceuticals (BXP), Alliance Pharma (APH), Poolbeg Pharma (POLB), INSPECS Group (SPEC), and e-therapeutics (ETX). These companies are all part of the "medical" sector.

Venture Life Group vs.

Venture Life Group (LON:VLG) and ECO Animal Health Group (LON:EAH) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, community ranking, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

ECO Animal Health Group received 136 more outperform votes than Venture Life Group when rated by MarketBeat users. Likewise, 75.65% of users gave ECO Animal Health Group an outperform vote while only 72.90% of users gave Venture Life Group an outperform vote.

CompanyUnderperformOutperform
Venture Life GroupOutperform Votes
156
72.90%
Underperform Votes
58
27.10%
ECO Animal Health GroupOutperform Votes
292
75.65%
Underperform Votes
94
24.35%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Venture Life Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Venture Life Group has higher earnings, but lower revenue than ECO Animal Health Group. ECO Animal Health Group is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venture Life Group£48.57M1.08£2.64M-£0.01-4,150.00
ECO Animal Health Group£88.46M0.82-£1.62M-£0.02-5,375.00

Venture Life Group has a net margin of -1.56% compared to ECO Animal Health Group's net margin of -1.83%. ECO Animal Health Group's return on equity of -0.24% beat Venture Life Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Venture Life Group-1.56% -1.02% 2.11%
ECO Animal Health Group -1.83%-0.24%0.69%

Venture Life Group has a beta of 0.27, suggesting that its share price is 73% less volatile than the S&P 500. Comparatively, ECO Animal Health Group has a beta of 0.07, suggesting that its share price is 93% less volatile than the S&P 500.

52.9% of Venture Life Group shares are owned by institutional investors. Comparatively, 95.9% of ECO Animal Health Group shares are owned by institutional investors. 7.5% of Venture Life Group shares are owned by insiders. Comparatively, 17.0% of ECO Animal Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Venture Life Group had 13 more articles in the media than ECO Animal Health Group. MarketBeat recorded 14 mentions for Venture Life Group and 1 mentions for ECO Animal Health Group. ECO Animal Health Group's average media sentiment score of 0.35 beat Venture Life Group's score of 0.15 indicating that ECO Animal Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Venture Life Group
2 Very Positive mention(s)
0 Positive mention(s)
10 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
ECO Animal Health Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Venture Life Group and ECO Animal Health Group tied by winning 8 of the 16 factors compared between the two stocks.

Get Venture Life Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VLG vs. The Competition

MetricVenture Life GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£52.50M£1.07B£4.85B£1.41B
Dividend Yield0.09%3.02%2.96%12.05%
P/E Ratio-4,136.601,164.71179.521,735.53
Price / Sales1.089,304.232,289.69313,051.50
Price / Cash6.4010.1446.3332.78
Price / Book0.723.264.762.53
Net Income£2.64M£102.53M£103.00M£180.63M
7 Day Performance6.41%-0.65%0.87%13.85%
1 Month Performance12.16%-0.31%-6.10%4.37%
1 Year Performance-2.92%28.73%10.03%16.94%

Venture Life Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EAH
ECO Animal Health Group
0 of 5 stars
GBX 93.03
-1.0%
N/A-10.9%£63.02M£88.46M-4,651.25234News Coverage
CEL
Celadon Pharmaceuticals
0 of 5 stars
GBX 115
flat
GBX 222.50
+93.5%
-34.4%£73.84M£11,258.00-884.6224Gap Up
PXS
Provexis
0 of 5 stars
GBX 0.60
-7.7%
N/A-9.0%£13.32M£426,168.0043.752High Trading Volume
ANCR
Animalcare Group
0 of 5 stars
GBX 214
-1.4%
N/A+19.5%£128.64M£74.35M10,700.00220News Coverage
AGY
Allergy Therapeutics
0 of 5 stars
GBX 2.90
+3.6%
N/A-54.4%£138.33M£59.59M-48.33612Gap Up
BXP
Beximco Pharmaceuticals
0 of 5 stars
GBX 37
flat
N/AN/A£165.06M£41.65B462.505,700
APH
Alliance Pharma
2.3417 of 5 stars
GBX 36
+1.4%
GBX 80.75
+124.3%
-42.5%£194.54M£170.05M-3,600.00285
POLB
Poolbeg Pharma
0 of 5 stars
GBX 10.43
-1.2%
N/A+55.9%£52.13MN/A-1,042.5012
SPEC
INSPECS Group
0 of 5 stars
GBX 51.11
-1.7%
N/A-47.6%£51.96M£202M-2,555.501,732
ETX
e-therapeutics
0 of 5 stars
GBX 8.80
-0.6%
N/A-32.6%£51.42M£295,000.00-440.0034Gap Down

Related Companies and Tools

This page (LON:VLG) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners